Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen.
Gabibov AG, Belogurov AA Jr, Lomakin YA, Zakharova MY, Avakyan ME, Dubrovskaya VV, Smirnov IV, Ivanov AS, Molnar AA, Gurtsevitch VE, Diduk SV, Smirnova KV, Avalle B, Sharanova SN, Tramontano A, Friboulet A, Boyko AN, Ponomarenko NA, Tikunova NV. Gabibov AG, et al. Among authors: lomakin ya. FASEB J. 2011 Dec;25(12):4211-21. doi: 10.1096/fj.11-190769. Epub 2011 Aug 22. FASEB J. 2011. PMID: 21859892
Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.
Lomakin YA, Zakharova MY, Stepanov AV, Dronina MA, Smirnov IV, Bobik TV, Pyrkov AY, Tikunova NV, Sharanova SN, Boitsov VM, Vyazmin SY, Kabilov MR, Tupikin AE, Krasnov AN, Bykova NA, Medvedeva YA, Fridman MV, Favorov AV, Ponomarenko NA, Dubina MV, Boyko AN, Vlassov VV, Belogurov AA Jr, Gabibov AG. Lomakin YA, et al. Mol Immunol. 2014 Dec;62(2):305-14. doi: 10.1016/j.molimm.2014.01.013. Epub 2014 Feb 16. Mol Immunol. 2014. PMID: 24534716 Free article.
Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.
Belogurov A Jr, Kuzina E, Kudriaeva A, Kononikhin A, Kovalchuk S, Surina Y, Smirnov I, Lomakin Y, Bacheva A, Stepanov A, Karpova Y, Lyupina Y, Kharybin O, Melamed D, Ponomarenko N, Sharova N, Nikolaev E, Gabibov A. Belogurov A Jr, et al. FASEB J. 2015 May;29(5):1901-13. doi: 10.1096/fj.14-259333. Epub 2015 Jan 29. FASEB J. 2015. PMID: 25634956 Free PMC article.
The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.
Ziganshin RH, Ivanova OM, Lomakin YA, Belogurov AA Jr, Kovalchuk SI, Azarkin IV, Arapidi GP, Anikanov NA, Shender VO, Piradov MA, Suponeva NA, Vorobyeva AA, Gabibov AG, Ivanov VT, Govorun VM. Ziganshin RH, et al. Among authors: lomakin ya. Mol Cell Proteomics. 2016 Jul;15(7):2366-78. doi: 10.1074/mcp.M115.056036. Epub 2016 May 3. Mol Cell Proteomics. 2016. PMID: 27143409 Free PMC article.
Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients.
Lomakin Y, Belogurov A Jr, Glagoleva I, Stepanov A, Zakharov K, Okunola J, Smirnov I, Genkin D, Gabibov A. Lomakin Y, et al. Mediators Inflamm. 2016;2016:2847232. doi: 10.1155/2016/2847232. Epub 2016 Apr 28. Mediators Inflamm. 2016. PMID: 27239100 Free PMC article. Clinical Trial.
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
Belogurov A Jr, Zakharov K, Lomakin Y, Surkov K, Avtushenko S, Kruglyakov P, Smirnov I, Makshakov G, Lockshin C, Gregoriadis G, Genkin D, Gabibov A, Evdoshenko E. Belogurov A Jr, et al. Neurotherapeutics. 2016 Oct;13(4):895-904. doi: 10.1007/s13311-016-0448-0. Neurotherapeutics. 2016. PMID: 27324388 Free PMC article. Clinical Trial.
Peptides Against Autoimmune Neurodegeneration.
Stepanov A, Lomakin Y, Gabibov A, Belogurov A. Stepanov A, et al. Curr Med Chem. 2017;24(17):1761-1771. doi: 10.2174/0929867324666170605092221. Curr Med Chem. 2017. PMID: 28578649 Review.
Divergent Immunomodulation Capacity of Individual Myelin Peptides-Components of Liposomal Therapeutic against Multiple Sclerosis.
Ivanova VV, Khaiboullina SF, Gomzikova MO, Martynova EV, Ferreira AM, Garanina EE, Sakhapov DI, Lomakin YA, Khaibullin TI, Granatov EV, Khabirov FA, Rizvanov AA, Gabibov A, Belogurov A Jr. Ivanova VV, et al. Among authors: lomakin ya. Front Immunol. 2017 Oct 16;8:1335. doi: 10.3389/fimmu.2017.01335. eCollection 2017. Front Immunol. 2017. PMID: 29085375 Free PMC article.
35 results